Project Grant K01CA304500
Award Date 8/21/26
Completion Date 7/30/31
Dollars Obligated $203K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23298, USA
Similar Awards
- The National Cancer Institute awarded Virginia Commonwealth University $129,194 on August 11, 2026, under the Cancer Treatment Research program (CFDA 93.395) to expand participation in National Cancer Institute-sponsored clinical trials through leadership development, education, and community partnerships. Keri R. Maher, DO, Medical Director of the Clinical Trials Office at Massey Comprehensive Cancer Center within VCU, will dedicate 25 percent effort to this work. She will implement a formal...
- Federal Cooperative Agreement Summary The Commonwealth of Virginia-State Board of Health (Richmond City Health District) received a $683,891 cooperative agreement awarded on August 30, 2025, from the Centers for Disease Control and Prevention (CDC) under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The five-year award, extending through August 29, 2030, funds the Virginia Colorectal Cancer Screening Project (VACCSP), which implements evidence-based...
- The National Cancer Institute awarded $415,257 to the University of Virginia on July 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop a comprehensive intervention addressing financial toxicity among cancer survivors and caregivers. The award funds a two-year project (July 1, 2026 through June 30, 2028) performed in Charlottesville, Virginia. The intervention will address all domains of financial toxicity—material burden, psychosocial distress, and coping...
- The National Institutes of Health National Cancer Institute awarded the University of North Carolina at Chapel Hill $645,317 on June 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct the My Body, My Test-4 trial, a randomized controlled study examining whether bundled outreach of at-home self-collection kits improves cervical and colorectal cancer screening coverage among under-screened women. The trial will enroll 2,499 women overdue for both screenings at...
- The National Cancer Institute awarded the University of Washington $203,939 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to implement a team-based care model designed to increase cervical cancer screening uptake in low-resource primary care settings. The project, titled "Implementing a Team-Based Care Model to Increase Cervical Cancer Screening Uptake in Low-Resource Primary Care Settings," addresses persistently low screening rates in rural and...
- The National Cancer Institute awarded the Regents of the University of Michigan $293,430 on June 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to study regional cancer care delivery across hub-and-spoke health systems. The research uses colon cancer as a test case to examine multidisciplinary care coordination within integrated health systems. The project leverages Michigan's Collaborative Quality Initiatives as a learning laboratory and pursues three primary aims:...
- The National Cancer Institute awarded Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) $639,477 on July 15, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a randomized controlled trial evaluating the impact of self-sampling tools on cancer screening completion and repeat screening among underscreened patients. The recipient will randomize 742 patients eligible but out-of-date with colorectal cancer screening and 250...
- The National Cancer Institute awarded Augusta University Research Institute, Inc. $395,973 on August 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct the CROSS (Cancer at the Crossroads) project, a population-based epidemiologic study evaluating how area-level social determinants of health impact early-onset colorectal cancer (EOCRC) outcomes. The project integrates Surveillance, Epidemiology, and End Results (SEER) 17 incidence data linked with county...
- The National Institute for Minority Health and Health Disparities awarded George Washington University $2,745,450 on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to evaluate an SMS text-based patient navigation intervention for colorectal cancer screening among persons experiencing homelessness. The project will deploy mHealth-based navigation through shelter-clinics operated by Project Renewal, a community organization serving the...
- The National Institute for Minority Health and Health Disparities awarded Oregon Health & Science University $3,117,935 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and test a culturally tailored home-based cervical and colorectal cancer screening intervention for American Indian and Alaska Native tribal communities. The funded work, titled "American Indian/Alaska Native Tailoring of a Home-Based Cervical and Colorectal...